Nantahala Capital Management, LLC Cogent Biosciences, Inc. Transaction History
Nantahala Capital Management, LLC
- $1.99 Billion
- Q4 2024
A detailed history of Nantahala Capital Management, LLC transactions in Cogent Biosciences, Inc. stock. As of the latest transaction made, Nantahala Capital Management, LLC holds 852,855 shares of COGT stock, worth $6.11 Million. This represents 0.33% of its overall portfolio holdings.
Number of Shares
852,855
Previous 790,936
7.83%
Holding current value
$6.11 Million
Previous $8.54 Million
22.13%
% of portfolio
0.33%
Previous 0.51%
Shares
5 transactions
Others Institutions Holding COGT
# of Institutions
190Shares Held
104MCall Options Held
157KPut Options Held
439K-
Kynam Capital Management, LP Princeton, NJ9.11MShares$65.3 Million4.5% of portfolio
-
Black Rock Inc. New York, NY7.29MShares$52.3 Million0.0% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA6.96MShares$49.9 Million8.87% of portfolio
-
Commodore Capital LP New York, NY6.88MShares$49.3 Million5.38% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA6.23MShares$44.6 Million9.76% of portfolio
About Cogent Biosciences, Inc.
- Ticker COGT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,758,300
- Market Cap $471M
- Description
- Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found ...